Fidelity Investments’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
LG
CFM
Fidelity Investments's CLPT Position: Q2 2026 in Review
Fidelity Investments increased its ClearPoint Neuro (CLPT) stake by 16% in Q2 2026, buying an estimated $16.6K and bringing the position to 9,501 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #3743.
Fidelity Investments first reported a position in CLPT in Q1 2022 and has held it in 18 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Fidelity Investments held 9,501 shares of ClearPoint Neuro worth $169K as of Q2 2026.
- Fidelity Investments bought 1,329 ClearPoint Neuro shares in Q2 2026, an estimated $16.6K.
- ClearPoint Neuro made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3743 holding.
- Fidelity Investments first reported a position in ClearPoint Neuro in Q1 2022 and has held it in 18 quarters since.
- 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.